Controversy brewing over Pharmaceutical Promotion Act

A controversy surrounding the enforcement of the Pharmaceutical Promotion Act is growing.

In a recent forum organized by a lawmaker, bioventure officials and some private economists argued that the special law should be scrapped. Instead, they say the government should work out measures to enhance the local biopharmaceutical industry.

However, pharmaceutical officials and proponents said ...